Case Study: Gilead achieves improved drug safety and accelerated AI readiness with TIBCO Software's Spotfire

Gilead Improves Drug Safety and Supports AI Roadmap with TIBCO Spotfire

Gilead, a research-based biopharmaceutical company, needed a more powerful analytics platform to keep pace with evolving pharmacovigilance and regulated R&D processes. The company sought interactive, exploratory visualizations that could support deeper discovery, real-time monitoring, and a future AI and open-source roadmap while meeting strict regulatory requirements.

By adopting TIBCO Spotfire across clinical, operations, submissions, and signal‑detection teams, Gilead gained real-time analytics, automated and customizable dashboards, and standardized workflows that improved early detection of drug‑safety issues. The deployment drove a 1,500% increase in report usage, cut report build time from years to months, produced interactive dashboards with zero maintenance, delivered a 50× reduction in report count for a single source of truth, and returned time savings and greater confidence for business teams while enabling future AI and data‑virtualization plans.

Gilead

Vishakha Mujoo

Manager of R&D Information Systems